Oral therapy for S. pneumoniae (pneumococcal) bronchiectasis exacerbations in children
If S. pneumoniae is isolated in the sputum sample of a child with a bronchiectasis exacerbation, useChang, 2023:
amoxicillin 25 mg/kg up to 1 g orally, 8-hourly; see advice on modification and duration of therapy. amoxicillin
For children who have had a nonsevere (immediate or delayed) hypersensitivity reaction to a penicillin1, use:
cefuroxime (child 3 months or older) 15 mg/kg up to 500 mg orally, 12-hourly; see advice on modification and duration of therapy. cefuroxime
For children who have had a severe (immediate or delayed)2 hypersensitivity reaction to a penicillin, or those who require an alternative oral liquid formulation, use the results of susceptibility testing to guide therapy. While awaiting results, use:
doxycycline orally, 12-hourly34; see advice on modification and duration of therapy doxycycline
child less than 21 kg: 2.2 mg/kg
child 21 to less than 26 kg: 50 mg
child 26 to 35 kg: 75 mg
child more than 35 kg: 100 mg.
If doxycycline cannot be used, while awaiting the results of susceptibility testing, other options are azithromycin, clarithromycin or moxifloxacin.
